Infergen
Links shared publicly online about this topic
Infergen gains expanded indication - MPR
empr.com — “The FDA has approved expanded labeling for Infergen (consensus interferon, from Three Rivers) to include its daily use in combination with ribavirin for retreatment of chronic hepatitis C patients.” View full resource at empr.com
Most Recently Shared on July 6, 2010 at 3:33 pm By:
MPR News: Infergen gains expanded indication: The FDA has approved expanded labeling for Infergen (consensus inter... http://bit.ly/dBm75t
Infergen gains expanded indication - ONA
oncologynurseadvisor.com — “The FDA has approved expanded labeling for Infergen (consensus interferon, from Three Rivers) to include its daily use in combination with ribavirin for retreatment of chronic hepatitis C patients.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 6, 2010 at 3:53 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Infergen gains expanded indication http://goo.gl/fb/E1kfE
FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram - Drugs.com MedNews
drugs.com — “SILVER SPRING, Md., May 3, 2011 - The FDA posted on its website a warning letter sent to Kadmon Pharmaceuticals regarding a STATgram for hepatitis C treatment I” View full resource at drugs.com
Most Recently Shared on May 3, 2011 at 5:06 pm By:
Drugs and Devices OW OW Health
FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram: SILVER SPRING, Md., May 3... http://bit.ly/iOjJM2 #drug
HCV New Drug Research: FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on May 4, 2011 at 2:46 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram http://goo.gl/fb/AZsm5
HCV New Drug Research: FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on May 4, 2011 at 2:27 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
HCV New Drug Research:FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram #hepatitis http://t.co/ZBuEBwT
Drug Updates For Primary Care
pdr.net — “Drug Updates For Primary Care” View full resource at pdr.net
Most Recently Shared on August 25, 2010 at 10:50 am By:
Physician Assistants Health News Feed
Drug updates for Aug 2010 from ePDR: http://www.pdr.net/edu/pcp_DrugUpdates.aspx Glassia, Aricept, Infergen, Arava
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
